We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Study Indicates a Lack of Diversity in COVID-19 Clinical Trials

News   Aug 12, 2020 | Original story from the University of Georgia

 
Study Indicates a Lack of Diversity in COVID-19 Clinical Trials

Credit: Dung Tran, Pixabay

 
 
Advertisement
 

RELATED ARTICLES

COVID-19 Vaccine Prioritization and the Impact of Non-Pharmaceutical Interventions

News

To effectively reduce SARS-CoV-2 transmission and improve long-term health, tactical delivery of COVID-19 vaccines is essential. This was the conclusion of a recent study published in PLOS Computational Biology. A team of UK-based researchers found that prioritizing the distribution of the vaccine to at-risk groups, including the elderly and those with underlying health conditions, had the greatest impact in terms of minimizing the number of lives lost to the disease.

READ MORE

Real-World Data Suggests Two Doses of Pfizer Vaccine Provides Over 95% Protection

News

An observational study published in The Lancet has explored the real-world effectiveness of the Pfizer–BioNTech mRNA COVID-19 vaccine (BNT162b2) against a variety of outcomes.

READ MORE

Cannabis-Derived Drug Exhibits Pain-Halting Effects in Mice

News

A novel cannabidiol (CBD) analog known as KLS-13019 prevented the development of neuropathy and reversed pain sensitivity in a mouse model of chemotherapy-induced peripheral neuropathy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE